ArticleBiomedicines2026

Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.

Antonio Sanz-Solas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.